Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis | Zendy

Maureen J.B. Aarts | Zendy; Birgit E. P. J. Vriens | Zendy; Maaike de Boer | Zendy; Frank Peters | Zendy; Caroline Mandigers | Zendy; M. Wouter Dercksen | Zendy; Jacqueline M. Stouthard | Zendy; Jolien Tol | Zendy; Laurence J. van Warmerdam | Zendy; Agnès J. van de Wouw | Zendy; Esther Jacobs | Zendy; Carin C.D. van der Rijt | Zendy; Tineke J. Smilde | Zendy; Annette W. van der Velden | Zendy; Nelly Peer | Zendy; Vivianne C. G. TjanHeijnen | Zendy

Open Access

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis

Author(s) -

Maureen J.B. Aarts,

Birgit E. P. J. Vriens,

Maaike de Boer,

Frank Peters,

Caroline Mandigers,

M. Wouter Dercksen,

Jacqueline M. Stouthard,

Jolien Tol,

Laurence J. van Warmerdam,

Agnès J. van de Wouw,

Esther Jacobs,

Carin C.D. van der Rijt,

Tineke J. Smilde,

Annette W. van der Velden,

Nelly Peer,

Vivianne C. G. TjanHeijnen

Publication year - 2017

Publication title -

oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.987

H-Index - 98

eISSN - 1423-0232

pISSN - 0030-2414

DOI - 10.1159/000479067

Subject(s) - docetaxel , medicine , granulocyte colony stimulating factor , chemotherapy , granulocyte , breast cancer , oncology , mammary gland , cancer , immunology

The primary outcome of the current study is, whether there is a protective effect of prior chemotherapy or of prior granulocyte colony-stimulating factor (G-CSF) on the next cycle blood cell counts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research